SEATTLE, April 07, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines ...
Atrasentan demonstrated mean proteinuria reductions of 38.1% proteinuria at six weeks of treatment, 48.3% at 12 weeks of treatment and 54.7% at 24 weeks of treatment There were no meaningful changes ...
In a recent study published in PLoS ONE, researchers assessed the binding of Galanthus nivalis agglutinin to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Study: Removal of ...
A team of scientists from China has recently deciphered the structural basis of comparatively higher binding affinity of two Omicron sub-variants, namely B.1.1 and B.2, for human ...
SAN ANTONIO, March 19, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) today released a study of a complex clinical case in which CyPath® Lung’s real-time assessment of the ...
Many well-known brands responded well to the disruption caused by the COVID-19 pandemic, according to consumers, a new survey released today by independent digital agency AFFINITY today reveals. The ...
An analysis of data from the National Health and Nutrition Examination Survey (2009–2020) found that men with higher sunlight affinity tend to have fewer depressive symptoms. They also reported ...
A randomized phase II clinical trial of enzalutamide in combination with the therapeutic cancer vaccine, PSA tricom, in metastatic, castration resistant prostate cancer. This is an ASCO Meeting ...
This new study, conducted by comScore Networks, found that site affinity is a greater driver of key brand metrics than frequency of ad exposure. In addition, the study concluded that in most cases, a ...
CHARLOTTE, N.C., June 19, 2025 /PRNewswire/ -- Affinity Group is proud to present the 2025 Operator Path to Purchase Study, a comprehensive look at the evolving factors influencing foodservice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results